Alok A Khorana

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 17

Top Venues

Journal for immunotherapy of cancer

Thrombosis and haemostasis

PloS one

JCO precision oncology

Cleveland Clinic

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Cleveland Clinic

United States

Vice-Chair, Taussig Cancer Institute; Professor of Medicine; Director, GI Malignancies Program :: Hematology and Medical Oncology

Publications

Alexander T Cohen, Christopher Wallenhorst, Marcella Rivera, Cihan Ay, Bernhard Schaefer, Khaled Abdelgawwad, George Psaroudakis, Gunnar Brobert, Anders Ekbom, Agnes Y Y Lee, Alok A Khorana, Cecilia Becattini, Marc Carrier, Craig I Coleman, Carlos Martinez
Comparison of Clinical Outcomes in Patients with Active Cancer Receiving Rivaroxaban or Low-Molecular-Weight Heparin: The OSCAR-UK Study. Thrombosis and haemostasis (2024)
Alexander Cohen, Christopher Wallenhorst, Marcela Rivera, Cihan Ay, Bernhard Schaefer, Khaled Abdelgawwad, George Psaroudakis, Gunnar Brobert, Anders Ekbom, Agnes Y Y Lee, Alok A Khorana, Cecilia Becattini, Marc Carrier, Craig I Coleman, Carlos Martinez
Comparison of Clinical Outcomes in Patients with Active Cancer Receiving Rivaroxaban or Low Molecular Weight Heparin - The OSCAR-UK Study. Thrombosis and haemostasis (2024)
Thejus T Jayakrishnan, Yasmine Baca, Joanne Xiu, Mehrie Patel, Benjamin A Weinberg, Emil Lou, Jashodeep Datta, Moh'd M Khushman, Pat Gulhati, Sanjay Goel, Tiago Biachi de Castria, Vaia Florou, Kanika G Nair, Suneel D Kamath, Alok A Khorana
Molecular Differences With Therapeutic Implications in Early-Onset Compared With Average-Onset Biliary Tract Cancers. JCO precision oncology 8 (2024)
Shyam K Poudel, Roshan Padmanabhan, Heloni Dave, Kathryn Guinta, Tyler Stevens, Madhusudhan R Sanaka, Prabhleen Chahal, Davendra P S Sohal, Alok A Khorana, Charis Eng
Microbiomic profiles of bile in patients with benign and malignant pancreaticobiliary disease. PloS one 18 (4) (2023)
Alok A Khorana, Jennell Palaia, Lisa Rosenblatt, Radhika Pisupati, Ning Huang, Chi Nguyen, John Barron, Kerrin Gallagher, T Christopher Bond
Venous thromboembolism incidence and risk factors associated with immune checkpoint inhibitors among patients with advanced non-small cell lung cancer. Journal for immunotherapy of cancer 11 (1) (2023)
Alok A Khorana, Jennell Palaia, Lisa Rosenblatt, Radhika Pisupati, Ning Huang, Chi Nguyen, John Barron, Kerrin Gallagher, T Christopher Bond
Venous thromboembolism incidence and risk factors associated with immune checkpoint inhibitors among patients with advanced non-small cell lung cancer. Journal for immunotherapy of cancer 11 (1) (2023)
Alok A Khorana, Jennell Palaia, Lisa Rosenblatt, Radhika Pisupati, Ning Huang, Chi Nguyen, John Barron, Kerrin Gallagher, T Christopher Bond
Venous thromboembolism incidence and risk factors associated with immune checkpoint inhibitors among patients with advanced non-small cell lung cancer. Journal for immunotherapy of cancer 11 (1) (2023)
Alok A Khorana, Jennell Palaia, Lisa Rosenblatt, Radhika Pisupati, Ning Huang, Chi Nguyen, John Barron, Kerrin Gallagher, T Christopher Bond
Venous thromboembolism incidence and risk factors associated with immune checkpoint inhibitors among patients with advanced non-small cell lung cancer. Journal for immunotherapy of cancer 11 (1) (2023)
Nigel S Key, Alok A Khorana, Nicole M Kuderer, Kari Bohlke, Agnes Y Y Lee, Juan I Arcelus, Sandra L Wong, Edward P Balaban, Christopher R Flowers, Leigh E Gates, Ajay K Kakkar, Margaret A Tempero, Shilpi Gupta, Gary H Lyman, Anna Falanga
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Guideline Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Alok A Khorana
Immune Checkpoint Inhibitors And Venous Thromboembolism: The More Things Change…. Thrombosis and haemostasis (2023)
Anna Falanga, Benjamin Brenner, Alok A Khorana, Charles W Francis
Thrombotic complications in patients with cancer: Advances in pathogenesis, prevention, and treatment-A report from ICTHIC 2021. Research and practice in thrombosis and haemostasis 6 (5) (2022)
Alok A Khorana, Nigel Mackman, Anna Falanga, Ingrid Pabinger, Simon Noble, Walter Ageno, Florian Moik, Agnes Y Y Lee
Cancer-associated venous thromboembolism. Nature reviews. Disease primers 8 (1) (2022)
Kristen M Sanfilippo, Tzu-Fei Wang, Marc Carrier, Anna Falanga, Brian F Gage, Alok A Khorana, Anthony Maraveyas, Gerald A Soff, Philip Stephen Wells, Jeffrey I Zwicker
Standardization of risk prediction model reporting in cancer-associated thrombosis: Communication from the ISTH SSC subcommittee on hemostasis and malignancy. Journal of thrombosis and haemostasis : JTH 20 (8) (2022)
Rajshekhar Chakraborty, Lisa Rybicki, Jason Valent, Alex V Mejia Garcia, Beth M Faiman, Jack Khouri, Christy J Samaras, Faiz Anwar, Alok A Khorana
Arterial thromboembolism in multiple myeloma in the context of modern anti-myeloma therapy. Blood cancer journal 11 (6) (2021)
Suneel D Kamath, Alok A Khorana
Does Sidedness Matter in Unresectable Colorectal Cancer? Annals of surgical oncology 26 (6) (2019)
Alok A Khorana
If Trousseau had a stroke. Blood 133 (8) (2019)
Alok A Khorana, Katherine Tullio, Paul Elson, Nathan A Pennell, Stephen R Grobmyer, Matthew F Kalady, Daniel Raymond, Jame Abraham, Eric E Klein, R Matthew Walsh, Emily E Monteleone, Wei Wei, Brian P Hobbs, Brian J Bolwell
Time to initial cancer treatment in the United States and association with survival over time: An observational study. PloS one 14 (3) (2019)

Alok A Khorana.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Alok A Khorana